文献速递浆细胞疾病

多发性骨髓瘤合并轻链沉积病患者的临床特征与预后因素

Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
PubMed 文献 · Am J Hematol · 2017-06-01

该研究分析了69例多发性骨髓瘤合并活检证实的轻链沉积病(LCDD)患者,报告了肾脏及肾外受累情况及其对预后的影响,以及肾脏缓解与血液学缓解的关系。合并淀粉样变性者生存倾向更短,心脏受累与总生存缩短相关,且干细胞移植后治疗相关死亡率显著更高。

要点

  • 30%的患者合并其他轻链疾病如AL淀粉样变性或管型肾病,合并淀粉样变性者生存倾向更短。
  • 三分之一患者存在LCDD心脏受累,与总生存缩短相关,且干细胞移植后治疗相关死亡率显著更高。
  • 需快速启动治疗以防止进行性肾病和更差结局,合并轻链疾病和心脏受累比既往报道更常见且预后更差。

核心结论

  • 多发性骨髓瘤合并LCDD患者临床特征与既往报道的LCDD队列不同。
  • 需快速启动治疗以防止进行性肾病和更差结局。
  • 合并轻链疾病和心脏受累比既往报道更常见,并导致更差临床结局,强调需仔细评估患者和治疗选择。

研究设计与样本

  • 分析了69例多发性骨髓瘤合并活检证实的轻链沉积病(LCDD)患者。
  • 报告了肾脏及肾外受累情况及其对预后的影响,以及肾脏缓解与血液学缓解的关系。

主要发现

  • 30%的患者合并其他轻链疾病如AL淀粉样变性或管型肾病。
  • 合并LCDD和淀粉样变性的患者生存倾向更短。
  • 三分之一患者存在LCDD心脏受累,与总生存缩短相关。
  • 心脏受累患者干细胞移植后治疗相关死亡率显著高于无心脏受累的LCDD患者。

临床怎么用

  • 作者认为需快速启动治疗以防止进行性肾病和更差结局。
  • 作者强调需仔细评估患者和治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Light chain deposition disease (LCDD) is characterized by monotypic immunoglobulin depositions which will eventually lead to loss of organ function if left untreated. While the kidney is almost always affected, the presence and degree of LCDD in other organs vary. Ten to thirty percent of LCDD patients have underlying Multiple Myeloma (MM), yet outcome and prognostic markers in this particular patient group are still lacking. Here, we analyzed 69 patients with MM and biopsy proven LCDD and report on renal and extra-renal involvement and its impact on prognosis as well as renal response depending on hematologic response. Coexisting light chain diseases such as AL amyloid and cast nephropathy were found in 30% of patients; those with LCDD and concurrent amyloid tended to have shorter survival. Cardiac involvement by LCDD was seen in one-third of our patients and was associated with shorter overall survival; such patients also had a significantly higher risk of treatment-related mortality (TRM) after stem cell transplant (SCT) compared to LCDD patients without cardiac involvement. This study highlights that MM patients with LCDD present with different clinical features compared to previously reported LCDD cohorts. Rapid initiation of treatment is necessary to prevent progressive renal disease and worse outcome. Coexisting light chain diseases and cardiac involvement are more common than previously reported and confer worse clinical outcome, emphasizing the need for careful patient careful patient evaluation and treatment selection.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Mohan M, Buros A, Mathur P, et al. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease. Am J Hematol. 2017. PMID: 28383130. doi:10.1002/ajh.24756

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。